Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer

Increased glucose uptake and metabolism is a prominent phenotype of most cancers, but efforts to clinically target this metabolic alteration have been challenging. Here, we present evidence that lactoylglutathione (LGSH), a byproduct of methylglyoxal detoxification, is elevated in both human and mur...

Full description

Bibliographic Details
Main Authors: Luengo, Alba (Author), Abbott, Keene L. (Author), Davidson, Shawn M. (Author), Hosios, Aaron M. (Author), Chan, Sze Ham (Author), Freinkman, Elizaveta (Author), Lewis, Caroline A. (Author), Vander Heiden, Matthew G. (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Whitehead Institute for Biomedical Research (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Springer Science and Business Media LLC, 2020-04-08T13:24:46Z.
Subjects:
Online Access:Get fulltext